Lopes Marta B, Wolff Jean-Claude, Bioucas-Dias José M, Figueiredo Mário A T
Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, Instituto Superior Técnico, 1049-001 Lisboa, Portugal.
Anal Chim Acta. 2009 May 8;641(1-2):46-51. doi: 10.1016/j.aca.2009.03.034. Epub 2009 Mar 26.
According to the WHO definition for counterfeit medicines, several categories can be established, e.g., medicines containing the correct active pharmaceutical ingredient (API) but different excipients, medicines containing low levels of API, no API or even a substitute API. Obviously, these different scenarios will have different detrimental effects on a patient's health. Establishing the degree of risk to the patient through determination of the composition of counterfeit medicines found in the market place is thus of paramount importance. In this work, classical least squares was used for predicting the composition of counterfeit Heptodin tablets found in a market survey. Near infrared chemical imaging (NIR-CI) was used as a non-destructive measurement technique. No prior knowledge about the origin and composition of the tablets was available. Good API (i.e., lamivudine) predictions were obtained, especially for tablets containing a high API (close to the authentic) dose. Concentration maps of each pure material, i.e., the API (lamivudine) and the excipients microcrystalline cellulose, sodium starch glycollate, rice starch and talc, were estimated. Below 1% of the energy was not explained by the model (residuals percentage) for every pixel in all 12 counterfeit tablets. The similarities among tablets with respect to the total API percentage determined, as well as the corresponding concentration maps, support the classification of the tablets into the different groups obtained in previous work.
根据世界卫生组织对假药的定义,可以确定几个类别,例如,含有正确活性药物成分(API)但辅料不同的药品、API含量低的药品、不含API甚至含有替代API的药品。显然,这些不同情况对患者健康会有不同的有害影响。因此,通过确定在市场上发现的假药成分来确定对患者的风险程度至关重要。在这项工作中,采用经典最小二乘法预测在市场调查中发现的假冒Heptodin片剂的成分。近红外化学成像(NIR-CI)被用作一种非破坏性测量技术。对片剂的来源和成分没有先验知识。获得了良好的API(即拉米夫定)预测结果,特别是对于含有高API(接近正品)剂量的片剂。估计了每种纯物质的浓度图,即API(拉米夫定)和辅料微晶纤维素、羟丙基淀粉钠、大米淀粉和滑石粉。在所有12片假冒片剂中,每个像素的模型未解释能量(残差百分比)低于1%。根据所确定的总API百分比以及相应的浓度图,片剂之间的相似性支持将片剂分类为先前工作中获得的不同组。